Viewing Study NCT04003103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-29 @ 2:33 PM
Study NCT ID: NCT04003103
Status: COMPLETED
Last Update Posted: 2025-07-18
First Post: 2019-06-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
Sponsor: Merck Sharp & Dohme LLC
Organization: